StockData
BeOne Medicines Ltd. logo

BeOne Medicines Ltd.

ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302252% above fair value
$361.27−9.06 (-2.45%)

Close on Nov 2, 2026Market cap $41.08BP/E 64.6Yield –

BeOne Medicines Noncurrent Long-Term Debt & Bank Loans by Year

Noncurrent Long-Term Debt & Bank Loans ($M) ($M)

BeOne Medicines Noncurrent Long-Term Debt & Bank Loans: $962M in FY2025, up 477.7% from a year earlier. That is the highest of the 10 years on record here.

Latest, FY2025
962
Period ended Dec 31, 2025
Change on a year earlier
+477.7%
167 in FY2024
History
10 years
Since FY2016
Sources
10
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-Q (filed 2026-08-05) ↗

Reported in Form 10-Q / 10-K Debt Note (XBRL).

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedNoncurrent Long-Term Debt & Bank Loans ($M) ($M)Year on yearSource
FY2025Dec 31, 2025962+477.7%Form 10-Q (filed 2026-08-05) ↗
FY2024Dec 31, 2024167-15.7%Form 10-K (filed 2026-02-26) ↗
FY2023Dec 31, 2023198-5.5%Form 10-K (filed 2025-02-27) ↗
FY2022Dec 31, 2022209+3.5%Form 10-K (filed 2024-02-26) ↗
FY2021Dec 31, 2021202+10.1%Form 10-K (filed 2023-02-27) ↗
FY2020Dec 31, 2020184+120.4%Form 10-K (filed 2022-02-28) ↗
FY2019Dec 31, 201983.3+104.2%Form 10-K (filed 2021-02-25) ↗
FY2018Dec 31, 201840.8+343.5%Form 10-K (filed 2020-03-02) ↗
FY2017Dec 31, 20179.20-46.8%Form 10-K (filed 2019-02-28) ↗
FY2016Dec 31, 201617.3–Form 10-K (filed 2018-02-28) ↗

Cite this data

StockData. (2026). BeOne Medicines Noncurrent Long-Term Debt & Bank Loans ($M), annual FY2016–FY2025 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/lt-debt-nc

See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.